Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy: A Prospective Study.

NCT06540456 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT06540456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06540456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy: A Prospective Study.
Lead sponsor
Medical University of South Carolina
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 13, 2025
Completion date
July 3, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower back pain, lumbosacral radiculopathy